Cubresa has secured a contract with Lawson Health Research Institute of London, Ontario, Canada, to supply the institute with its investigational BrainPET system.
Lawson will use BrainPET in neurological research studies in three areas:
- Developing a way to differentiate between types of dementia using PET and MRI
- Assessing a new method for "quantifying cognitive reserve" among the elderly
- To explore changes in the density of synapses and the role of inflammation in psychiatric disorders, neurodegeneration and cognitive disability following a major cardiac event, the company said.
Cubresa BrainPET is an investigational device and is not available for commercial sale. Image courtesy of Cubresa.BrainPET can be used with 1.5-tesla, 3-tesla, and 7-tesla MRI systems, Cubresa said.
